Northstar Group’s AstraZeneca AZN Stock Holding History

Northstar Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$231K	Sell	1,216 -56	-4%	-$10.5K	0.03%	161
2026 Q1	$251K	Sell	1,272 -175	-12%	-$33.7K	0.04%	144
2025 Q4	$266K	Sell	1,447 -203	-12%	-$35.6K	0.04%	144
2025 Q3	$253K	Sell	1,650 -790	-32%	-$120K	0.04%	136
2025 Q2	$341K	Sell	2,440 -92	-4%	-$12.9K	0.05%	117
2025 Q1	$372K	Sell	2,532 -251	-9%	-$36.3K	0.06%	110
2024 Q4	$365K	Hold	2,783	–	–	0.06%	108
2024 Q3	$434K	Sell	2,783 -88	-3%	-$14.2K	0.08%	97
2024 Q2	$448K	Hold	2,871	–	–	0.08%	90
2024 Q1	$389K	Hold	2,871	–	–	0.08%	104
2023 Q4	$387K	Sell	2,871 -510	-15%	-$66.3K	0.08%	98
2023 Q3	$458K	Hold	3,381	–	–	0.11%	90
2023 Q2	$484K	Buy	3,381 +58	+2%	+$8.53K	0.11%	89
2023 Q1	$461K	Hold	3,323	–	–	0.12%	90
2022 Q4	$451K	Hold	3,323	–	–	0.13%	90
2022 Q3	$364K	Hold	3,323	–	–	0.11%	101
2022 Q2	$439K	Hold	3,323	–	–	0.13%	93
2022 Q1	$441K	Hold	3,323	–	–	0.11%	101
2021 Q4	$387K	Buy	+3,323	New	+$391K	0.09%	109

Other funds holding AZN

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

CDDEC

Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

BTCPP

Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

ISS

Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM

Northstar Group's AZN Position: Q2 2026 in Review

Northstar Group reduced its AstraZeneca (AZN) stake by 4.4% in Q2 2026, selling an estimated $10.5K and leaving 1,216 shares worth $231K. The position accounts for 0.03% of the portfolio, ranked #161.

Northstar Group first reported a position in AZN in Q4 2021 and has held it in 19 quarters since. The position peaked at $484K in Q2 2023. 700 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Northstar Group held 1,216 shares of AstraZeneca worth $231K as of Q2 2026.
Northstar Group sold 56 AstraZeneca shares in Q2 2026, an estimated $10.5K.
AstraZeneca made up 0.03% of Northstar Group's portfolio in Q2 2026, its #161 holding.
Northstar Group first reported a position in AstraZeneca in Q4 2021 and has held it in 19 quarters since.
Northstar Group's AstraZeneca position peaked at $484K in Q2 2023.
700 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Northstar Group's 13F filing for Q2 2026, filed 3 Aug 2026.